Same Old Supplement Claim Violations Prompt US Regulators’ Action Under New COVID-19 Authority
Executive Summary
FTC files complaint against Quickwork as first action under authority granted in the COVID-19 Consumer Protection Act. The enforcement came after the firm twice ingored warnings to discontinue claims its vitamin D and zinc supplements were equal to or more effective than current vaccines.
You may also be interested in...
False Treatment Claims Still A COVID-19 Symptom: FTC Files Complaint Against California Firm
FTC files complaint alleging Precision Patient Outcomes marketed a supplement as a treatment to mitigate the effects of COVID-19 after agency let the firm know it considered the claims false advertising.
Direct Seller’s Advertising Mixing Boosting Health With Building Wealth Made Known To FTC
Bulavita didn’t respond to Direct Selling Regulatory Council’s inquiry on claims its supplements could boost the immune system against COVID-19. In an assessment of the claims, the industry self-regulation group it would refer its questions to the FTC.
US Puts Price Tag On False COVID-19 Claims
Until coronavirus public health emergency ends, FTC is authorized to order civil penalties of $43,792 per violation found in COVID-19-related advertising. Health care providers, meanwhile, advertising to treat COVID-19 might be unfamiliar with